New analysis confirms Siemens Healthineers PCR influenza assays detect new H3N2 influenza strain exhibiting genetic drifts.†
†Data on file at Fast Track Diagnostics Luxembourg S.à r.l., a Siemens Healthineers Company. Data is current as of date 30th November 2022.
Acute respiratory pathogen infections are common causes of acute local and systemic disease with substantial morbidity and mortality in pediatric, adult, and immunocompromised patients. Early and accurate diagnosis of respiratory pathogens diminishes transmission and complications. More efficient laboratory testing enables the physician to determine appropriate and timely patient treatment.1,2
Siemens Healthineers offers solutions for the simultaneous detection of several respiratory pathogens:
- FTD SARS-CoV-2 Assay3 for the specific detection of the coronavirus causing COVID-19
- FTD SARS-CoV-2/FluA/FluB/HRSV Assay4 for the detection and differentiation of SARS-CoV-2, IAV, IBV, and HRSV A/B
- FTD Respiratory Pathogens 21 Assay4 for the detection of 20 viruses and 1 bacterium
- FTD FLU/HRSV Assay4 for the detection of influenza A, influenza B, and human respiratory syncytial viruses A and B